Nicox【ALCOX】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.302

買値

0.296

売値

0.302

出来高

101,343

0.296 日の範囲 0.302

0.14 52 週間の範囲 0.4915

時価総額

15.191M

前日終値

0.302

始値

0.296

時刻

0.302

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

145,351

発行済株式数

50,299,694

配当利回り

PER

-13.66

1 株当たり利益 (EPS)

-0.42

歳入

7.14M

純利益

-20.88M

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.nicox.com

本社

Antibes, Alpes-maritimes, Fra

設立

Nicox SA is listed in the Pharmaceutical Preparations sector of the ユーロネクスト with ticker ALCOX. The last closing price for Nicox was 0.30 €. Over the last year, Nicox shares have traded in a share price range of 0.14 € to 0.4915 €.

Nicox currently has 50,299,694 shares in issue. The market capitalisation of Nicox is 15.19 € million. Nicox has a price to earnings ratio (PE ratio) of -13.66.

Nicox annonce la première vente commerciale de ZERVIATE en Chine par son partenaire Ocumension, création d’une nouvelle source de revenus récurrents

Nicox annonce la première vente commerciale de ZERVIATE en Chine par son partenaire Ocumension, création d’une nouvelle source de revenus récurrents Communiqué de presseNicox annonce la première...

Nicox Announces First Commercial Sale of ZERVIATE in China by Partner Ocumension, Creating a New Recurrent Revenue Stream

Nicox Announces First Commercial Sale of ZERVIATE in China by Partner Ocumension, Creating a New Recurrent Revenue Stream Press Release Nicox Announces First Commercial Sale of ZERVIATE in China...

Nicox : Recrutement de patients achevé plus tôt que prévu en Chine dans l’étude clinique de phase 3 Denali sur NCX 470

Nicox : Recrutement de patients achevé plus tôt que prévu en Chine dans l’étude clinique de phase 3 Denali sur NCX 470 Communiqué de presseNicox : Recrutement de patients achevé plus tôt que prévu...

Nicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected

Nicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected Press ReleaseNicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected Confirms...

Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470

Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470 Communiqué de presseNicox annonce la publication de la partie adaptive de l’étude clinique...

Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc Phase 3 Trial

Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc Phase 3 Trial Press Release Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc...

Nicox : Point financier sur le troisième trimestre 2024 et résultats financiers du premier semestre 2024

Nicox : Point financier sur le troisième trimestre 2024 et résultats financiers du premier semestre 2024 Communiqué de presseNicox : Point financier sur le troisième trimestre 2024 et résultats...

Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results

Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results Press Release Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results Topline results from...

Nicox et Soleus signent un accord de financement de 16,5 millions de dollars combinant la vente de redevances et un financement en fonds propres

Nicox et Soleus signent un accord de financement de 16,5 millions de dollars combinant la vente de redevances et un financement en fonds propres Communiqué de presse Nicox et Soleus signent un...

Nicox and Soleus Sign $16.5 million Royalty and Equity Financing

Nicox and Soleus Sign $16.5 million Royalty and Equity Financing Press Release Nicox and Soleus Sign $16.5 million Royalty and Equity Financing Gross proceeds of $15 million (€13.7 million) for...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.019	-5.91900311526	0.321	0.326	0.2905	116548	0.30622709	DE
4	0.008	2.72108843537	0.294	0.335	0.28	138646	0.30800085	DE
12	0.0425	16.3776493256	0.2595	0.335	0.2005	145351	0.27782696	DE
26	0.115	61.4973262032	0.187	0.335	0.14	256466	0.25571256	DE
52	-0.1135	-27.3164861613	0.4155	0.4915	0.14	173129	0.26582941	DE
156	-0.28	-48.1099656357	0.582	0.65	0.14	137839	0.31864537	DE
260	-0.28	-48.1099656357	0.582	0.65	0.14	137839	0.31864537	DE

ALCOX - Frequently Asked Questions (FAQ)

What is the current Nicox share price?

The current share price of Nicox is 0.302 €

How many Nicox shares are in issue?

Nicox has 50,299,694 shares in issue

What is the market cap of Nicox?

The market capitalisation of Nicox is EUR 15.19M

What is the 1 year trading range for Nicox share price?

Nicox has traded in the range of 0.14 € to 0.4915 € during the past year

What is the PE ratio of Nicox?

The price to earnings ratio of Nicox is -13.66

What is the cash to sales ratio of Nicox?

The cash to sales ratio of Nicox is 39.93

What is the reporting currency for Nicox?

Nicox reports financial results in EUR

What is the latest annual turnover for Nicox?

The latest annual turnover of Nicox is EUR 7.14M

What is the latest annual profit for Nicox?

The latest annual profit of Nicox is EUR -20.88M

What is the registered address of Nicox?

The registered address for Nicox is SUNDESK SOPHIA ANTIPOLIS ,EMERALD SQUARE, B��TIMENT C, RUE EVARISTE GALOIS, BIOT, ANTIBES, ALPES-MARITIMES, 06410

What is the Nicox website address?

The website address for Nicox is www.nicox.com

Which industry sector does Nicox operate in?

Nicox operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
DRVDSDrone Volt	0.0039 € (3,800.00%)	774.48k
GTRDSGroupe Tera DS	0.0585 € (800.00%)	3.27k
ALCYBCybergun	0.0002 € (100.00%)	3.98M
DMSBSDiagnostic Medical Systems	0.0075 € (87.50%)	129.59k
NICBSNicox SA	0.0265 € (50.57%)	979
MLSMLSmalto	0.014 € (-33.33%)	1.62k
ALVERVergnet	0.0015 € (-21.05%)	97.17M
MLIDSIds	0.364 € (-19.11%)	1.12k
MCPGrupo Media Capital Sgps Sa	1.62 € (-19.00%)	3
ALBOOBOOSTHEAT	0.063 € (-15.78%)	70.91k
ATOAtos SE	0.002 € (-4.76%)	2.53B
ALVERVergnet	0.0015 € (-21.05%)	97.17M
BCPBanco Comercial Portugues SA	0.4988 € (0.79%)	69.25M
EDPEDP SA	3.149 € (1.22%)	13.56M
VIVVivendi SE	2.546 € (-1.01%)	8.93M